Genmab CEO on legal fight with Janssen: Standing up straight and fighting for what's morally and ethically right

The trial between collaborative partners Genmab and Janssen is moving along, but according to Jan van de Winkel it's too early to conclude when a verdict will be made.
Photo: Mik Eskestad/ERH
Photo: Mik Eskestad/ERH
BY BENJAMIN WERNER CHRISTENSEN, TRANSLATED BY NIELSINE NIELSEN

Genmab and its CEO Jan van de Winkel will fight to the last breath in in its current dispute with US partner Janssen. At least, that is the impression you get from speaking to the Dutch bussinessman.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading